The company activity began from Innovita Research Foundation, a private foundation, which from 2001 was helping researchers working in the field of anti-aging medicine. At 2005 the foundation was re-structurized to Innovita Research company. During 19 years activity, Innovita Research performed and initiated a number of scientific projects in anti-aging medicine, immunotherapeutic approach for cancer treatment and regenerative medicine, which resulted in a number of scientific papers, patents and developed technologies. In 2020 the company has opened a clinic to provide immunotherapy and regenerative medicine services.
The company uses Good Laboratory Practice (GLP) certified entities system for research activity and Good Manufacturing Practice (GMP) certified entities for small-scale production of cellular products for preclinical investigations.
Innovita Research also offers high quality pre-clinical trials performance service of any kind of customer substance, device or technology.